Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjord JE, et al. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med. 1997;75:758–61.

Article  CAS  PubMed  Google Scholar 

Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, et al. DNA-repair defects and olaparib in metastatic prostate cancer. N. Engl J Med. 2015;373:1697–708.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N. Engl J Med. 2016;375:443–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate cancer, Version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21:1067–96.

Article  CAS  PubMed  Google Scholar 

Armstrong AJ, Taylor A, Haffner MC, Abida W, Bryce AH, Karsh LI, et al. Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2). Prostate Cancer Prostatic Dis. 2024.

Barata PC, Assayag J, Li B, Siu G, Niyazov A Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer. JAMA Oncology. 2024.

Shore N, Gazi M, Pieczonka C, Heron S, Modh R, Cahn D, et al. Efficacy of national comprehensive cancer network guidelines in identifying pathogenic germline variants among unselected patients with prostate cancer: the PROCLAIM Trial. Eur Urol Oncol. 2023;6:477–83.

Article  PubMed  Google Scholar 

Fonseca NM, Maurice-Dror C, Herberts C, Tu W, Fan W, Murtha AJ. et al.Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.Nat Commun. 2024;15:1828

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russo J, McDougall C, Bowler N, Shimada A, Gross L, Hyatt C, et al. Pretest genetic education video versus genetic counseling for men considering prostate cancer germline testing: a patient-choice study to address urgent practice needs. JCO Precis Oncol. 2021;5:1377−86.

Loeb S, Keith SW, Cheng HH, Leader AE, Gross L, Sanchez Nolasco T, et al. TARGET: a randomized, noninferiority trial of a pretest, patient-driven genetic education webtool versus genetic counseling for prostate cancer germline testing. JCO Precis Oncol 2024;8:e2300552.

Article  PubMed  PubMed Central  Google Scholar